Michael David Katz M.D. - 24 Jan 2023 Form 4 Insider Report for Hanover Bancorp, Inc. /NY (HNVR)

Role
Director
Signature
/s/ Gregory Krauss, POA
Issuer symbol
HNVR
Transactions as of
24 Jan 2023
Net transactions value
$0
Form type
4
Filing time
26 Jan 2023, 14:59:00 UTC
Previous filing
15 Aug 2022
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HNVR Common Stock Award $0 +1,612 +1.1% $0.000000 144,405 24 Jan 2023 Direct F1
holding HNVR Common Stock 40 24 Jan 2023 See Footnote 2 F2
holding HNVR Common Stock 25 24 Jan 2023 See Footnote 2 F2
holding HNVR Common Stock 96,760 24 Jan 2023 See Footnote 3 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028.
F2 Held as custodian for Dr. Katz's grandchild
F3 Held by a trust to which Dr. Katz is a beneficiary